• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MIF 通过结合 HVEM 并激活 NF-κB 信号通路促进桥本甲状腺炎中 Th17 细胞的分化。

MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-κB signaling pathway.

机构信息

Department of Laboratory Medicine, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Foshan, Guangdong, China.

Department of Medical Research Center, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Foshan, Guangdong, China.

出版信息

Int Immunopharmacol. 2023 Aug;121:110494. doi: 10.1016/j.intimp.2023.110494. Epub 2023 Jun 16.

DOI:10.1016/j.intimp.2023.110494
Abstract

Hashimoto's thyroiditis is a typical thyroid autoimmune disease and Th17 cells are crucial in its development. In recent years, MIF (Macrophage Migration Inhibitory Factor) has been found to promote the secretion of IL-17A and the production and differentiation of Th17 cells. However, the specific mechanism of it remains unclear. Here, we found that the expression of MIF, IL-17A and HVEM (Herpes Virus Entry Mediator) were up-regulated in HT patients. The proportion of Th17 cells in peripheral blood mononuclear cells was positively correlated with the serum MIF protein level. We further found that the expression of HVEM and the phosphorylation level of NF-κB in peripheral blood mononuclear cells of HT patients were significantly increased. Therefore, we speculated that MIF promotes Th17 cell differentiation through HVEM and NF-κB signaling pathways. Further mechanism studies showed that MIF could directly bind to HVEM, and the stimulation of rhMIF in vitro could increase the expression of HVEM and activate NF-κB signaling pathways to promote Th17 cell differentiation. After blocking HVEM with HVEM antibody, the effect of MIF on Th17 cell differentiation disappeared. The results above show that the differentiation of Th17 cells is promoted by MIF combined with HVEM through NF-κB signaling pathways. Our research provides a new theory to the regulation mechanism of Th17 cell differentiation and gives hint to new potential therapeutic targets for HT.

摘要

桥本甲状腺炎是一种典型的甲状腺自身免疫性疾病,Th17 细胞在其发生发展中起关键作用。近年来发现,MIF(巨噬细胞移动抑制因子)可促进 IL-17A 的分泌以及 Th17 细胞的产生和分化。但其具体机制尚不清楚。本研究发现,桥本甲状腺炎患者 MIF、IL-17A 和 HVEM(疱疹病毒进入介体)的表达上调,外周血单个核细胞中 Th17 细胞的比例与血清 MIF 蛋白水平呈正相关。进一步发现桥本甲状腺炎患者外周血单个核细胞中 HVEM 的表达和 NF-κB 的磷酸化水平显著增加。因此,我们推测 MIF 通过 HVEM 和 NF-κB 信号通路促进 Th17 细胞分化。进一步的机制研究表明,MIF 可以直接与 HVEM 结合,体外 rhMIF 的刺激可以增加 HVEM 的表达并激活 NF-κB 信号通路,从而促进 Th17 细胞分化。用 HVEM 抗体阻断 HVEM 后,MIF 对 Th17 细胞分化的作用消失。上述结果表明,MIF 通过 NF-κB 信号通路与 HVEM 结合促进 Th17 细胞分化。本研究为 Th17 细胞分化的调节机制提供了新的理论依据,为桥本甲状腺炎的治疗提供了新的潜在靶点。

相似文献

1
MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-κB signaling pathway.MIF 通过结合 HVEM 并激活 NF-κB 信号通路促进桥本甲状腺炎中 Th17 细胞的分化。
Int Immunopharmacol. 2023 Aug;121:110494. doi: 10.1016/j.intimp.2023.110494. Epub 2023 Jun 16.
2
Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.与辅助性T细胞17相互作用的巨噬细胞移动抑制因子可能参与桥本甲状腺炎自身免疫损伤的发病机制。
Mediators Inflamm. 2015;2015:621072. doi: 10.1155/2015/621072. Epub 2015 Mar 15.
3
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.功能性 MIF 启动子单倍型调节对照受试者和类风湿关节炎患者外周血单个核细胞中 Th17 相关细胞因子的表达。
Cytokine. 2019 Mar;115:89-96. doi: 10.1016/j.cyto.2018.11.014. Epub 2018 Nov 19.
4
Macrophage migration inhibitory factor (MIF) inhibitor iSO-1 promotes staphylococcal protein A-induced osteogenic differentiation by inhibiting NF-κB signaling pathway.巨噬细胞移动抑制因子(MIF)抑制剂iSO-1通过抑制核因子κB(NF-κB)信号通路促进葡萄球菌蛋白A诱导的成骨分化。
Int Immunopharmacol. 2023 Feb;115:109600. doi: 10.1016/j.intimp.2022.109600. Epub 2022 Dec 26.
5
Elevated MicroRNA-326 Levels Regulate the IL-23/IL-23R/Th17 Cell Axis in Hashimoto's Thyroiditis by Targeting a Disintegrin and Metalloprotease 17.微 RNA-326 水平升高通过靶向解整合素金属蛋白酶 17 调节桥本甲状腺炎中的 IL-23/IL-23R/Th17 细胞轴。
Thyroid. 2020 Sep;30(9):1327-1337. doi: 10.1089/thy.2019.0552. Epub 2020 Apr 24.
6
MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.MIF 促进人原代细胞培养中 Th1/Th2/Th17 炎症反应的差异:健康受试者 PBMC 中 Th17 细胞因子谱占优势,活动期 SLE 患者 PBMC 中 IL-6 和 TNF-α 增加。
Cell Immunol. 2018 Feb;324:42-49. doi: 10.1016/j.cellimm.2017.12.010. Epub 2017 Dec 26.
7
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.巨噬细胞移动抑制因子通过促进核因子-κB 的激活来调节白细胞介素-6 的产生,从而在创伤弧菌感染期间发生。
BMC Immunol. 2010 Oct 12;11:50. doi: 10.1186/1471-2172-11-50.
8
New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.深入了解巨噬细胞移动抑制因子在系统性红斑狼疮类固醇耐药患者中的作用和机制。
Arthritis Res Ther. 2012 May 2;14(3):R103. doi: 10.1186/ar3828.
9
HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.低氧诱导因子-α/巨噬细胞移动抑制因子(HIF-α/MIF)和核因子-κB/白细胞介素-6(NF-κB/IL-6)信号轴在头颈部鳞状细胞癌(HNSCC)的低氧微环境中促使CD11b+Gr-1+髓样细胞募集。
Neoplasia. 2014 Feb;16(2):168-79. doi: 10.1593/neo.132034.
10
HDAC6-specific inhibitor alleviates hashimoto's thyroiditis through inhibition of Th17 cell differentiation.HDAC6特异性抑制剂通过抑制Th17细胞分化减轻桥本甲状腺炎。
Mol Immunol. 2022 Sep;149:39-47. doi: 10.1016/j.molimm.2022.05.004. Epub 2022 Jun 16.

引用本文的文献

1
Effect of Thyroxine Replacement Therapy on Serum Maresin 1 and NF-kB Levels in Patients with Hashimoto Thyroiditis.甲状腺素替代疗法对桥本甲状腺炎患者血清maresin 1和NF-κB水平的影响。
Diagnostics (Basel). 2025 May 14;15(10):1248. doi: 10.3390/diagnostics15101248.
2
Mechanical sensing protein PIEZO1 controls osteoarthritis via glycolysis mediated mesenchymal stem cells-Th17 cells crosstalk.机械传感蛋白PIEZO1通过糖酵解介导的间充质干细胞-Th17细胞串扰控制骨关节炎。
Cell Death Dis. 2025 Apr 1;16(1):231. doi: 10.1038/s41419-025-07577-1.
3
MIF promotes Th17 cell differentiation in rheumatoid arthritis through ATF6 signal pathway.
MIF 通过 ATF6 信号通路促进类风湿关节炎中的 Th17 细胞分化。
Mol Med. 2024 Nov 29;30(1):237. doi: 10.1186/s10020-024-01005-4.
4
Associations between immune cell traits and autoimmune thyroid diseases: a bidirectional two-sample mendelian randomization study.免疫细胞特征与自身免疫性甲状腺疾病之间的关联:一项双向两样本孟德尔随机化研究。
Immunogenetics. 2024 Aug;76(4):219-231. doi: 10.1007/s00251-024-01345-9. Epub 2024 Jun 28.
5
Kurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition.苦参酮通过抑制Rac1调节Th17/Treg平衡并改善自身免疫性葡萄膜炎。
J Adv Res. 2025 Mar;69:381-398. doi: 10.1016/j.jare.2024.03.013. Epub 2024 Mar 24.
6
Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming.高选择性MIF酮酶抑制剂KRP-6可减少M1巨噬细胞极化和代谢重编程。
Antioxidants (Basel). 2023 Sep 22;12(10):1790. doi: 10.3390/antiox12101790.